A Rare Presentation Of Sepsis Associated Metabolic Encephalopathy With Superadded Uremic Encephalopathy – A Case Report
DOI:
https://doi.org/10.63682/jns.v14i14S.4377Keywords:
Metabolic encephalopathy, Sepsis-associated encephalopathy, Uremic encephalopathy, Lentiform fork sign, White matter disease, Central nervous system, ProcalcitoninAbstract
Background: Sepsis-associated metabolic encephalopathy is seen in critically ill patients. Uremia worsens sepsis, causing significant cognitive and mental status changes.
Objective: To highlight the imaging patterns of septic and uremic encephalopathy.
Methods: The patient was brought to the emergency with decreased responsiveness for 2 days. Comprehensive lab evaluations and imaging studies were conducted.
Results: Imaging diagnosis was made based on the characteristic brain parenchymal changes in correlation with clinical and lab parameters. On follow up post treatment changes revealed resolution of brain parenchymal changes and improved patient’s clinical status.
Discussion: Imaging in septic and metabolic encephalopathy reveals bilateral symmetrical and characteristic changes such as diffuse white matter hyperintensities in brain stem in septic and the Lentiform fork sign in uremic encephalopathy.
Conclusion: Clinicians should correlate lab parameters and imaging patterns with altered mental status to optimize treatment.
Downloads
References
Mahoney CA, Sarnacki P, Arieff AI. Uremic encephalopathy: role of brain energy metabolism. Am J Physiol. 1984;247(3 Pt 2).
Olano C, Akram S, Bhatt H. Uremic encephalopathy. 2024. [PubMed].
M. D. G, et al. Metabolic encephalopathy: a review. J Neurol. 2021.
Gofton T, Young G. Sepsis-associated encephalopathy. Nat Rev Neurol. 2012;8:557–66. https://doi.org/10.1038/nrneurol.2012.183.
Kumar G, Goyal MK. Lentiform fork sign: a unique MRI picture. Is metabolic acidosis responsible? Clin Neurol Neurosurg. 2010;112(9):805–12. doi:10.1016/j.clineuro.2010.06.006. [PubMed].
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.